Identification of in vivo metabolites of a potential anti-rheumatoid arthritis compound, the quinazolinone derivative PD110, using ultra-high performance liquid chromatography coupled with Q-Exactive plus mass spectrometrys

References

• Chang J, Chen H, Chen J, Sun X, Wu X, Liu L, Xu Z, Chen W, Zhang J, Wang X, et al. 2021. Characterization of the metabolite of cabozantinib generated from liver microsomes and hepatocytes by ultra-high performance liquid chromatography coupled to quadrupole/orbitrap high resolution mass spectrometry. J Pharm Biomed Anal. 205:114343.
   PubMed Web of Science ®Google Scholar
• Cushing TD, Hao X, Shin Y, Andrews K, Brown M, Cardozo M, Chen Y, Duquette J, Fisher B, Gonzalez-Lopez de Turiso F, et al. 2015. Discovery and in vivo evaluation of (S)-N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine (AMG319) and related PI3Kδ inhibitors for inflammation and autoimmune disease. J Med Chem. 58(1):480–511.
   PubMed Web of Science ®Google Scholar
• Garces AE, Stocks MJ. 2019. Class 1 PI3K clinical candidates and recent inhibitor design strategies: a medicinal chemistry perspective. J Med Chem. 62(10):4815–4850.
   PubMed Web of Science ®Google Scholar
• Ghigo A, Damilano F, Braccini L, Hirsch E. 2010. PI3K inhibition in inflammation: toward tailored therapies for specific diseases. Bioessays. 32(3):185–196.
   PubMed Web of Science ®Google Scholar
• Hawkins PT, Stephens LR. 2015. PI3K signalling in inflammation. Biochim Biophys Acta. 1851(6):882–897.
   PubMed Web of Science ®Google Scholar
• Jia H, Dai G, Su W, Xiao K, Weng J, Zhang Z, Wang Q, Yuan T, Shi F, Zhang Z, et al. 2019. Discovery, optimization, and evaluation of potent and highly selective PI3Kγ-PI3Kδ dual inhibitors. J Med Chem. 62(10):4936–4948.
   PubMed Web of Science ®Google Scholar
• Li J, Li L, Wang Y, Zhao Y, Hu P, Xu Z, Liu F, Liang Q, Tian X, Huang C. 2021. Systematic investigation on the anti-rheumatoid arthritis material basis and mechanism of Juan Bi Tang. Part 1: integrating metabolic profiles and network pharmacology. J Pharm Biomed Anal. 202:114133.
   PubMed Web of Science ®Google Scholar
• Liu J, Tang M, Lai H, Dong Y, Xie C, Ye H, Ma L, Qiu N, Li Y, Cai L, et al. 2013. Identification of metabolites of honokiol in rat urine using 13C stable isotope labeling and liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry. J Chromatogr A. 1295:48–56.
   PubMed Web of Science ®Google Scholar
• Liu K, Li D, Zheng W, Shi M, Chen Y, Tang M, Yang T, Zhao M, Deng D, Zhang C, et al. 2021. Discovery, optimization, and evaluation of quinazolinone derivatives with novel linkers as orally efficacious phosphoinositide-3-kinase delta inhibitors for treatment of inflammatory diseases. J Med Chem. 64(13):8951–8970.
   PubMed Web of Science ®Google Scholar
• Liu S, Ma H, Zhang H, Deng C, Xin P. 2021. Recent advances on signaling pathways and their inhibitors in rheumatoid arthritis. Clin Immunol. 230:108793.
   PubMed Web of Science ®Google Scholar
• Methot JL, Zhou H, Kattar SD, McGowan MA, Wilson K, Garcia Y, Deng Y, Altman M, Fradera X, Lesburg C, et al. 2019. Structure overhaul affords a potent purine PI3Kδ inhibitor with improved tolerability. J Med Chem. 62(9):4370–4382.
   PubMed Web of Science ®Google Scholar
• Panday NK, Thakkar D, Patel S, Shard A, Sengupta P. 2021. Metabolite profiling of IMID-2, a novel anticancer molecule of piperazine derivative: in silico prediction, in vitro and in vivo metabolite characterization using UPLC-QTOF-MS/MS. Biomed Chromatogr. 35(6):e5082.
   PubMed Web of Science ®Google Scholar
• Patel L, Chandrasekhar J, Evarts J, Forseth K, Haran AC, Ip C, Kashishian A, Kim M, Koditek D, Koppenol S, et al. 2016. Discovery of orally efficacious phosphoinositide 3-Kinase δ inhibitors with improved metabolic stability. J Med Chem. 59(19):9228–9242.
   PubMed Web of Science ®Google Scholar
• Patel L, Chandrasekhar J, Evarts J, Haran AC, Ip C, Kaplan JA, Kim M, Koditek D, Lad L, Lepist EI, et al. 2016. 2,4,6-triaminopyrimidine as a novel hinge binder in a series of PI3Kδ selective inhibitors. J Med Chem. 59(7):3532–3548.
   PubMed Web of Science ®Google Scholar
• Sahu AK, Sengupta P. 2020. Time of flight mass spectrometry based in vitro and in vivo metabolite profiling of ribociclib and their toxicity prediction. J Chromatogr B Analyt Technol Biomed Life Sci. 1147:122142.
   PubMed Web of Science ®Google Scholar
• Saidi M, Kamali S, Beaudry F. 2019. Neuropeptidomics: comparison of parallel reaction monitoring and data-independent acquisition for the analysis of neuropeptides using high-resolution mass spectrometry. Biomed Chromatogr. 33(7):e4523.
   PubMed Web of Science ®Google Scholar
• Shin Y, Suchomel J, Cardozo M, Duquette J, He X, Henne K, Hu YL, Kelly RC, McCarter J, McGee LR, et al. 2016. Discovery, optimization, and in vivo evaluation of benzimidazole derivatives AM-8508 and AM-9635 as potent and selective PI3Kδ inhibitors. J Med Chem. 59(1):431–447.
   PubMed Web of Science ®Google Scholar
• Singh A, Thatikonda T, Kumar A, Wazir P, V V, Nandi U, Singh PP, Singh S, Gupta AP, Tikoo MK, et al. 2018. Determination of ZSTK474, a novel Pan PI3K inhibitor in mouse plasma by LC-MS/MS and its application to pharmacokinetics. J Pharm Biomed Anal. 149:387–393.
   PubMed Web of Science ®Google Scholar
• Somoza JR, Koditek D, Villasenor AG, Novikov N, Wong MH, Liclican A, Xing W, Lagpacan L, Wang R, Schultz BE, et al. 2015. Structural, biochemical, and biophysical characterization of idelalisib binding to phosphoinositide 3-kinase δ. J Biol Chem. 290(13):8439–8446.
   PubMed Web of Science ®Google Scholar
• Wang H, Li X, Ye H, Qiu N, Ma L, Wang C, Yang Q, Tang M, Wan L, Chen L. 2016. Characterization of in vivo metabolites of a potential anti-obesity compound, the 3-Methyl-1H-Purine-2,6-Dione Derivative C-11, employing ultra-high performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. Chromatographia. 79(11–12):693–702.
   Web of Science ®Google Scholar
• Yao J, Jiang X, Liu Q, Yuan X, Feng T, Li K, Zhao L. 2019. An available strategy based on accurate mass by ultra high performance liquid chromatography coupled to Fourier transform ion cyclotron resonance mass spectrometry technology to characterization of metabolic profile of palbociclib in rat urine, feces and bile. J Chromatogr B Analyt Technol Biomed Life Sci. 1124:37–46.
   PubMed Web of Science ®Google Scholar
• Yuan L, Li J, Feng M, Zou XR. 2021. Identification of the metabolites of XL092 in rat and human by using ultra-high performance liquid chromatography high resolution mass spectrometry. J Pharm Biomed Anal. 206:114390.
   PubMed Web of Science ®Google Scholar
• Zhou J, Chen J, Hu C, Xie Z, Li H, Wei S, Wang D, Wen C, Xu G. 2016. Exploration of the serum metabolite signature in patients with rheumatoid arthritis using gas chromatography-mass spectrometry. J Pharm Biomed Anal. 127:60–67.
   PubMed Web of Science ®Google Scholar